- Home
- APMD vs XPEL Comparison
APMD vs XPEL Comparison
Compare APMD & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APMD | XPEL |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2026 | 2019 |
Fundamental Metrics
Financial Performance| Metric | APMD | XPEL |
|---|---|---|
| Price | $26.40 | $49.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $56.00 |
| AVG Volume (30 Days) | ★ 380.2K | 209.2K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.12 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $476,200,000.00 |
| Revenue This Year | N/A | $12.64 |
| Revenue Next Year | N/A | $11.98 |
| P/E Ratio | ★ N/A | $47.83 |
| Revenue Growth | N/A | ★ 13.27 |
| 52 Week Low | $20.02 | $31.50 |
| 52 Week High | $35.29 | $55.91 |
Technical Indicators
Market Signals| Indicator | APMD | XPEL |
|---|---|---|
| Relative Strength Index (RSI) | 48.62 | 47.85 |
| Support Level | $23.98 | $45.60 |
| Resistance Level | $30.34 | $49.41 |
| Average True Range (ATR) | 3.25 | 1.24 |
| MACD | -0.41 | -0.30 |
| Stochastic Oscillator | 9.43 | 0.00 |
Price Performance
Historical ComparisonAbout APMD Apnimed Inc. Common Stock
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.